Author:
Carter Kimberly L.,Streiff Michael B.,Ross Patricia A.,Wellman Jessica C.,Thomas Michelle L.,Kraus Peggy S.,Shermock Kenneth M.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference20 articles.
1. Kanagasabapathy P, Chowdary P, Gatt A (2010) Alternatives to warfarin—the next generation of anticoagulants. Cardiovasc Ther 00:1–9
2. Boehringer Ingelheim Pharmaceuticals (2010) Pradaxa (dabigatran) package insert, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA
3. Jassen Pharmaceuticals (2011) Xarelto (rivaroxaban) package insert, Jassen Pharmaceuticals, Titusville, NJ, USA
4. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151
5. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrilliation. N Engl J Med 365:883–891
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献